# WellTok

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/welltok

- Industry: Software
- Headquarters: Denver, US
- Website: www.welltok.com
- Total disclosed funding: $268M
- Latest round: Series E (Apr 5, 2018)
- Investors on record: 26

## About

Welltok, Inc. is a Denver-based healthcare technology company that offers a health engagement platform to enhance consumer health activation and support personalized health journeys through advanced data analytics.Founded in 2009 and headquartered in Denver, US, Welltok, Inc. specializes in consumer health engagement solutions. In November 2021, the company was acquired by Virgin Pulse, Inc., allowing for expanded health engagement capabilities. The firm has raised a total of USD 10.44 mn through several funding rounds, with its most recent funding, Series E, occurring in 2021. The CEO of Welltok is Bob Fabbio, who has a history of founding and leading technology-driven companies.Welltok offers a comprehensive consumer activation platform designed to enhance health engagement across various sectors of the healthcare industry. Their core product utilizes advanced data analytics to connect consumers with tailored health improvement resources, facilitating personalized journeys toward better health and wellbeing. The platform serves a diverse clientele including health plans, employers, healthcare providers, and public entities, aiming to empower end users by providing actionable insights and rewards for health-related activities. Welltok's solutions have been deployed in various geographical markets, primarily in the United States, addressing the specific needs of consumers seeking to optimize their health through personalized recommendations and resources. The overarching objective of Welltok's offerings is to streamline the consumer experience in navigating health services and improving health outcomes.Welltok's revenue model primarily centers around subscription-based services tailored to their enterprise clients within the healthcare sector. Clients engage in partnerships that allow them to access Welltok’s platform, which facilitates the integration of personalized health resources for their members or employees. This transaction structure fosters a B2B relationship, where health plans, employers, and public entities subscribe to the platform to enhance member engagement in health improvement activities. Welltok’s flagship products are designed to drive consumer activation and participation in health initiatives, potentially leading to improved health outcomes and reduced healthcare costs for clients. Specific pricing plans and transaction details are structured based on the unique needs of each client, ensuring flexibility and alignment with their health objectives.Following its acquisition in November 2021, Welltok is set to enhance its health engagement capabilities, integrating its personalization and analytics into Virgin Pulse’s Homebase for Health. This strategic move aims to provide greater value to clients and their respective populations. Plans for future growth include launching new health engagement products, although specific release dates are not yet disclosed. Additionally, Welltok seeks to expand its market presence beyond the United States, targeting specific new geographic regions as part of its growth strategy. The funding from the Series E round will be utilized to support these initiatives, particularly in reducing costs for clients and enhancing overall service delivery.

## Funding rounds

- Series E, Apr 5, 2018, $50M — New Enterprise Associates, Itochu, Future Fund, Bessemer Venture Partners, Nan Fung Group, Georgian, Ziff Davis, Inc.
- Series E, Sep 15, 2016, $44M — InterWest Partners, New Enterprise Associates, Foundation Medical Partners, Miramar, Emergence Capital, HLM Venture Partners, Okapi Venture Capital, Bessemer Venture Partners, SG Growth Capital, Qualcomm Ventures, Georgian, Hearst Ventures, Trustmark Companies, Sigma Partners, Flare Capital Partners
- Series D, Nov 20, 2015, $38M — InterWest Partners, Foundation Medical Partners, SG Growth Capital, Georgian, Flare Capital Partners
- Series D, Aug 5, 2015, $45M — InterWest Partners, New Enterprise Associates, Miramar, Emergence Capital, Bessemer Venture Partners
- Series D, May 8, 2015, $21M — InterWest Partners, New Enterprise Associates, Miramar, Emergence Capital, Bessemer Venture Partners, Qualcomm Ventures
- Series D, Oct 1, 2014, $25M — InterWest Partners, New Enterprise Associates, Miramar, Emergence Capital, Bessemer Venture Partners, Hearst Ventures, Catholic Health Initiatives Operating Investment Program
- Series C, Dec 13, 2013, $22M — InterWest Partners, New Enterprise Associates, Miramar, Emergence Capital, IBM Ventures, Okapi Venture Capital, Qualcomm Ventures
- Series B, Mar 26, 2013, $19M — InterWest Partners, New Enterprise Associates, Miramar, Emergence Capital, Okapi Venture Capital, The TriZetto Group, Inc.
- Series A, Jul 2, 2012, $2.1M — Domain Associates, Oaktree Capital Management, Miramar, Wedbush Capital Partners, Okapi Venture Capital, DynaFund Ventures
- Series A, Aug 24, 2011, $0.8M — Miramar, Okapi Venture Capital, The TriZetto Group, Inc.
- Series A, May 5, 2011, $1.7M — Okapi Venture Capital

## Investors

- Okapi Venture Capital (https://capitalatlas.ai/funds/okapi-venture-capital) — Series A, Series B, Series C, Series E
- Miramar (https://capitalatlas.ai/funds/miramar) — Series A, Series B, Series C, Series D, Series E
- The TriZetto Group, Inc. — Series A, Series B
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Oaktree Capital Management (https://capitalatlas.ai/funds/oaktree-capital-management) — Series A
- Wedbush Capital Partners (https://capitalatlas.ai/funds/wedbush-capital-partners) — Series A
- DynaFund Ventures (https://capitalatlas.ai/funds/dynafund-ventures) — Series A
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series B, Series C, Series D, Series E
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B, Series C, Series D, Series E
- Emergence Capital (https://capitalatlas.ai/funds/emergence-capital) — Series B, Series C, Series D, Series E
- IBM Ventures (https://capitalatlas.ai/funds/ibm-ventures) — Series C
- Qualcomm Ventures (https://capitalatlas.ai/funds/qualcomm-ventures) — Series C, Series D, Series E
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series D, Series E
- Hearst Ventures (https://capitalatlas.ai/funds/hearst-ventures) — Series D, Series E
- Catholic Health Initiatives Operating Investment Program (https://capitalatlas.ai/funds/catholic-health-initiatives-operating-investment-program) — Series D
- Foundation Medical Partners (https://capitalatlas.ai/funds/foundation-medical-partners) — Series D, Series E
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series D, Series E
- Georgian — Series D, Series E
- Flare Capital Partners (https://capitalatlas.ai/funds/flare-capital-partners) — Series D, Series E
- HLM Venture Partners (https://capitalatlas.ai/funds/hlm-venture-partners) — Series E
- Trustmark Companies — Series E
- Sigma Partners — Series E
- Itochu — Series E
- Future Fund — Series E
- Nan Fung Group — Series E
- Ziff Davis, Inc. — Series E